|
E.V. Biryukova, I.V. Solovyova
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
|
№4 / 2019
|
|
N.S. Alekseeva (1), E.V. Beloborodova (2)
The effectiveness of therapeutic measures in metabolic syndrome and vitamin d deficiency
|
№4 / 2019
|
|
A.F. Verbovoy, Yu.A. Dolgikh, O.V. Kosareva, L.A. Sharonova, I.A. Tsanava
INSULIN RESISTANCE AND THYROID HORMONES
|
№5 / 2017
|
|
L.A. Sharonova, A.F. Verbovoy, I.A. Tsanava
STATE OF CARDIOVASCULAR SYSTEM IN METABOLIC SYNDROME
|
№5 / 2017
|
|
A.F. Verbovoy, L.A. Sharonova, A.V. Pashentseva, I.A. Tsanava
INSULIN RESISTANCE SYNDROME IN THE CLINIC OF INTERNAL DISEASES
|
№5 / 2017
|
|
A.S. Ametov
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
|
№5 / 2017
|
|
S.N. Tolstov (1, 2), I.A. Salov (1, 2), A.P. Rebrov (1)
SEVERITY OF ABDOMINAL OBESITY AND CARBOHYDRATE METABOLISM DISORDERS IN MENOPAUSAL WOMEN AND POTENTIALS FOR THE CORRECTION OF THE REVEALED VIOLATIONS
|
№3 / 2017
|
|
A.F. Verbovoy, R.I. Sagirova, Yu. A. Dolgikh, L.A. Sharonova
SOME ASPECTS OF PATHOGENESIS OF INSULIN RESISTANCE
|
№16 / 2016
|
|
L.V. Egshatyan (1), A.M. Mkrtumyan (1), L.A. Zvenigorodskaya (2)
METABOLIC SYNDROME AND INTESTINAL MICROBIOTA
|
№16 / 2016
|
|
A.F. Verbovoy, I.A. Tsanava, N.I. Verdovaya
ADIPOKINES AND HORMONAL AND METABOLIC PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND GOUT
|
№17 / 2015
|
|
E.A. Strebkova, L.I. Alekseeva
OSTEOARTHROSIS AND METABOLIC SYNDROME
|
№17 / 2015
|
|
A.F. Verbovoy, L.A. Sharonova, R.I. Akhmerova
EFFECTS OF SHORT-TERM THERAPY WITH ROSUVASTATIN ON LIPID METABOLISM IN PATIENTS WITH CORONARY ARTERY DISEASE
|
№16 / 2014
|
Русский
